The aim of the study was to analyze the frequency of thyroid carcinoma in a consecutive series of 539 thyroidectomies for multinodular goiter (MNG) and to assess the influence of sex and age as cancer risk factors.
Methods
In a 2-year period, 539 patients underwent subtotal or total thyroidectomy for MNG at the Institute of General Surgery, University of Padova, Padova, Italy: 455 were females and 84 males (F/M = 5.5/1); mean age was 46 years (min. 17, max 78). Only 17 patients (3.1%) (16 females and 1 male) were aged 21 years or less.
Results
A malignancy was found in 41 patients: 38 females and 3 males; 39 older and 2 younger than 21 years. The frequency of cancer in MNG was 7.6%: 8.3% in females and 3.6% in males; 7.5% in patients older than 21 and 11.7% under 21 years.
Conclusions
The combination of MNG and carcinoma should always be carefully considered but not overemphasized, and the policy of surgically treating all patients with MNG is not justified. Sex and age cannot be considered as factors of a higher risk of cancer.
AttieJ.N., KhafifR.A.: Preservation of parathyroid glands during total thyroidectomy. Am. J. Surg., 131: 399–404, 1975.
2.
BlondeauP.: La chirurgie thyroidienne actuelle. Risques recurentiels et parathyroidiens. Nouv. Presse. Med.:2: 3007–3008, 1973.
3.
BondesonL., LujenbergO.: Occult thyroid carcinoma at autopsy in Malmo, Sweden. Cancer, 47: 319–323, 1981.
4.
BranderA., ViikinkoskiP., NickelsJ., KivisaariL.: Thyroid gland: US screening in middle-aged women with no previous thyroid disease. Radiology, 173: 507–510, 1989.
5.
CampanaF.P.: I carcinomi incidentali della tiroide. Chirurgia, 7: 394–398, 1994.
6.
CarditelloA.: Thyreopathies nodulaires. J. Chir. Paris., 127: 330–333, 1990.
7.
ChristensenS.B.: Natural history of thyroid carcinoma. Lancet, 2: 1428–1430, 1985.
8.
De GrootL.J., LarsenP.R., RefetoffS., StanburyJ.B.: Endemic goitre and related disorders. In: The thyroid and its diseases, De GrootL.J., LarsenP.R., RefetoffS., StanburyJ.B. (Eds.), 5th edn., pp. 642–680, John Wiley, New York, 1984.
9.
FreemanS.L., HayI.D., BeogstralhE.J., GoellenerJ.R., OffordK.P., KurlandL.T.: Epidemiology, treatment and outcome of thyroid carcinoma through five decades. Endocrinology, 119: 65–71, 1986.
10.
FukunagaF.H., LockettJ.: Thyroid carcinoma in the Japanese in Hawaii. Arch. Pathol., 1: 6–13, 1971.
11.
GagarkinG.N., UzhvaV.P., GagarkinI.G.: Nodular goiter from the oncologic view point. Khirurgiia-Mosk., 7: 41–43, 1994.
12.
GaitanE., NelsonN.C., PooleG.V.: Endemic goiter and endemic thyroid disorders. World. J. Surg.: 15, 205–215, 1991.
13.
HaracH.R., FransillaK.I., WseniusV.: Occult papillary carcinoma of the thyroid. Cancer, 56: 531–538, 1985.
14.
KohK.B.H., ChangK.W.: Carcinoma in multinodular goitre. Br. J. Surg., 79: 266–267, 1992.
15.
LangerP.: History of goiter, WHO Ed. Monogr. Ser. 44, Geneva, WHO, 1960.
16.
MathaiV., IdikulaJ., FennA.S., NairA.: Do long-standing nodular goitres result in malignancies? Aust. N.Z. J. Surg., 64: 180–182, 1994.
17.
MazzaferriE.L.: Management of a solitary thyroid nodule. N. Engl. J. Med., 328: 553–559, 1993.
18.
MazzaferriE.L.: Solitary thyroid nodule. Post. Grad. Med., 1: 98–101, 1981.
19.
McCallA., JaroszH., LawrenceA.M., PaloyanE.: The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery, 100: 1128–1132, 1986.
20.
McHenryC., SmithM., LawrenceA.M., JaroszH., PaloyanE.: Nodular thyroid disease in children and adolescents. Am. Surg., 54: 444–447, 1988.
21.
MoneyW.L., RawsonR.W.: The experimental production of thyroid tumors in the rat exposed to prolonged treatment with thiouracil. Cancer, 3: 321–324, 1950.
22.
MortensenJ.D.: Gross and microscopic findings in clinically normal thyroid glands. J. Clin. Endocrinol. Metab., 15: 1270–1280, 1955.
23.
PelizzoM.R., PiottoA., RubelloD., CasaraD., FassinaA., BusnardoB.: High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori, 76: 255–257, 1990.
24.
PelizzoM.R., ToniatoA., PiottoA., BernanteP.: Epidemiologia e fattori di rischio del carcinoma della tiroide. Chirurgia Ital., 46: 1–3, 1994.
25.
PelizzoM.R., ToniatoA., BernanteP., Maffei FaccioliA.: Tecnica e risultati della tiroidectomia totale nella terapia del carcinoma della tiroide. Chirurgia, 1: 229–234, 1988.
26.
RallisonM.L., DobynsB.M., MeikleA.W., BishopM., LyionJ.L., StevensW.: Natural history of thyroid abnormalities: prevalence, incidence and regression of thyroid diseases in adolescents and young adults. Am. J. Med., 91: 363–370, 1991.
27.
RiccabonaG.: The thyroid cancer and endemic goiter, pp. 333–350, John Wiley, New York, 1980.
28.
RodierJ.F., JanserJ.C., RodierD.: Place de la thyroidectomie totale dans le traitement des goitres multiheteronodulaires. J. Chir. Paris, 128: 403–408, 1991.
SchneiderA.B., PinskyS., BekermanC., Yun RyoU.: Characteristics of 108 thyroid cancers detected by screening in a population with a history of head and neck irradiation. Cancer, 46: 1218–1227, 1980.
31.
SquartiniF.: Frequenza e significato del cancro tiroideo occulta. Agg. Med., 3: 279–285, 1983.
32.
SquiffletJ.P., MouradM.: Incidence of thyroid carcinoma in a common surgical practice. Acta Chir. Belg., 94: 23–24, 1994.
WalfishP.G.: A prospective study of combined ultrasonography and needle aspiration biopsy in the assessment of the hypofunctioning thyroid nodule. Surgery, 82: 474–476, 1977.
37.
WardR.: California cancer commission studies: Cancer of thyroid. Calif. Med., 68: 170–172, 1948.
38.
WegelinC.: Malignant disease of the thyroid gland and its relation to goitre in man and animals. Cancer Rev., 3: 297–299, 1928.
39.
WeissW.: Changing incidence of thyroid cancer. J. Natl. Cancer Inst., 62: 1137–1142, 1979.
40.
WheelerM.H.: The thyroid gland and the thyroglossal tract. Surgery, 20th edn., pp. 660–693, H.K. Lewis, London, 1988.
41.
WilliamsE.D.: Epidemiology and genetic factors in thyroid carcinoma. Acta Endocrinol., 252: 11–12, 1983.
42.
WoolnerL.B., LemmonM.L., BeahrsO.H., BlackB.M., KeatingF.R.: Occult papillary carcinoma of the thyroid gland. A study of 140 cases observed in a 30 year period. J. Clin. Endocrinol., 20: 89–105, 1960.
43.
ZoharY.: Endemic goiter in a non-goitrogenic country. Harefuah, 127: 75–78, 1994.
